Today: 8 November 2025
Subscribe
Browse Tag

acquisitions

Schwab to Acquire Forge Global in $660 Million All‑Cash Deal, Accelerating the Race to Retail Access for Private Shares (Nov. 6, 2025)

Schwab to Acquire Forge Global in $660 Million All‑Cash Deal, Accelerating the Race to Retail Access for Private Shares (Nov. 6, 2025)

The deal at a glance Schwab will acquire all of Forge’s issued and outstanding common shares for $45 in cash per share. The companies expect to close in the first half of 2026, subject to customary approvals. Forge’s two largest shareholders—Motive Capital and Deutsche Börse—have signed support agreements backing the transaction. Business Wire According to the announcement, Forge operates a marketplace and associated infrastructure that has facilitated more than $17 billion in trades of private‑company shares. Schwab scheduled a webcast at 8:30 a.m. ET today to discuss the transaction. Business Wire Why it matters Private companies—from AI leaders to space and
6 November 2025
 ·  ·  ·  ·  ·  · 
Huntington Bancshares’ Bold Moves: Strong Earnings and a $7.4B Bank Takeover Shake Up HBAN Stock

Huntington Bancshares’ Bold Moves: Strong Earnings and a $7.4B Bank Takeover Shake Up HBAN Stock

October 27, 2025: Huntington Bancshares Incorporated (NASDAQ: HBAN) is making headlines with a potent mix of robust earnings and aggressive expansion. The Columbus, Ohio-based regional bank is riding high on better-than-expected Q3 results and announcing a $7.4 billion takeover of Cadence Bank, a bold merger that extends Huntington’s footprint into the lucrative Texas and Southeast markets. Investors are parsing what these developments mean for HBAN’s stock price and future. Stock Price and Recent Trading Action As of October 27, Huntington’s stock is hovering near $15.5 per share in afternoon trading. That price is down a few percent from Friday’s close,
27 October 2025
 ·  ·  ·  ·  · 
Huntington’s $7.4B Texas-Tupelo Power Move: Cadence Bank Takeover Shakes Up Banking

Huntington’s $7.4B Texas-Tupelo Power Move: Cadence Bank Takeover Shakes Up Banking

Deal Details and Rationale On Oct. 27, Huntington Bancshares announced it will absorb Cadence Bank in a stock-for-stock merger finimize.com sec.gov. Cadence is a $53 billion-asset regional bank based in Houston/Tupelo, with 390 branches in eight states sec.gov bankingdive.com. Under the deal Huntington will issue 2.475 of its shares per Cadence share. Based on HBAN’s Oct. 24 close of $16.07, the exchange price equals $39.77 per Cadence share (a ~9% premium) finimize.com bankingdive.com. This values Cadence at $7.4 billion in total finimize.com bankingdive.com. The combined bank will have about $276 billion in assets, $220 billion in deposits, and $184 billion in loans and leases reuters.com bankingdive.com.
27 October 2025
 ·  ·  ·  ·  ·  · 
DraftKings Bets Big: Railbird Acquisition and NBC Deal Ignite Investor Frenzy

DraftKings Bets Big: Railbird Acquisition and NBC Deal Ignite Investor Frenzy

Record Revenue, Rising Margins Drive Optimism In early August, DraftKings reported blowout Q2 results – revenue of $1.51 billion (up 37% YoY) and adjusted EBITDA of $301 million, more than double the prior record investing.com. Management noted strong sportsbook hold and growth in monthly active users. CEO Jason Robins said, “We set records for revenue, net income and Adjusted EBITDA in the second quarter” investing.com. The company reaffirmed its full-year outlook, expecting to hit the high end of $6.2–6.4B revenue and roughly $850M EBITDA investing.com. The upbeat results lifted DraftKings shares (they rose ~4% immediately after release investing.com) and helped narrow the
25 October 2025
 ·  ·  ·  · 
Blackstone (BX) Shines With Big Q3 Beat & $18B Hologic Deal – But Why Are Shares Falling?

Blackstone (BX) Shines With Big Q3 Beat & $18B Hologic Deal – But Why Are Shares Falling?

Q3 Earnings and Market Reaction Blackstone’s latest results (for the quarter ended Sept. 30) painted a mixed picture. The firm reported distributable earnings of $1.889 billion ($1.52 per share), up 48% from a year ago and well above the $1.23 forecast reuters.com. (Distributable earnings roughly measure cash profits available for dividends.) However, on a GAAP basis net income dropped to $624.9 million ($0.80/share) from $780.8 million last year, and total revenue slid about 15.7% year-over-year ts2.tech. Investors focused on the earnings miss and slowing revenue, which partly offset the beat on cash profit. As a result, BX shares dipped about 1% intraday on Oct. 23,
23 October 2025
 ·  ·  ·  ·  ·  · 
DocGo (NASDAQ: DCGO) Stock Rockets After Virtual Care Acquisition – Can the Rally Last?

DocGo (NASDAQ: DCGO) Stock Rockets After Virtual Care Acquisition – Can the Rally Last?

Stock Surges on SteadyMD Acquisition DocGo’s shares jumped more than 34% in after-hours trading on Oct. 20, 2025, after the company announced it would acquire SteadyMD, a virtual care platform. According to an Investing.com report, DocGo stock “surged 34.6% in after-hours trading Monday following the company’s announcement that it has acquired virtual care platform SteadyMD” m.uk.investing.com. The acquisition was disclosed on Monday, Oct. 20, and a conference call to discuss it was scheduled for Oct. 21. SteadyMD brings a nationwide telehealth network (600+ clinicians serving ~3 million patients in 2025) to DocGo’s existing mobile health and ambulance services citybiz.co m.uk.investing.com.
21 October 2025
 ·  ·  ·  ·  · 
Bristol Myers Snaps Up Orbital Therapeutics in $1.5B Biotech Power Play

Bristol Myers Snaps Up Orbital Therapeutics in $1.5B Biotech Power Play

In-Depth Analysis BMS’s acquisition of Orbital Therapeutics marks a deliberate push into autoimmune disease treatment via advanced cell therapy. Orbital, founded in 2022 by leaders in RNA and immunology, has built a proprietary RNA platform combining circular and linear RNA engineering with sophisticated lipid nanoparticle (LNP) delivery news.bms.com fiercebiotech.com. Its lead program, OTX-201, is designed as an in vivo CAR‑T: instead of harvesting and engineering cells outside the body, Orbital will inject circular RNA encoding a CD19-directed CAR into the patient, so the patient’s own T cells become the “manufacturers” of CAR‑T cells in situ news.bms.com orbitaltx.com. This approach could
10 October 2025
 ·  ·  ·  ·  · 
Confluent, Inc. (CFLT) – Will a Real‑Time Data Pioneer Become a Takeover Target? (October 8 2025)

Confluent, Inc. (CFLT) – Will a Real‑Time Data Pioneer Become a Takeover Target? (October 8 2025)

Stock Price & Short‑Term Performance Confluent trades on the NASDAQ under ticker CFLT. According to the company’s historical price lookup, the stock closed at $21.26 on 6 Oct 2025 and dropped to $20.73 on 7 Oct investors.confluent.io. Technical analysis from StockInvest.us notes the stock fell 2.49 % on 7 Oct, trading between $20.12 and $21.33, and it has declined in six of the last ten sessions stockinvest.us. Volume was ~7 M shares, lower than earlier sessions, suggesting reduced risk stockinvest.us. The near‑term outlook is cautious: the share price is in a falling short‑term trend with predicted downside of almost 19 % if the trend persists. However, both
8 October 2025
 ·  ·  ·  ·  · 
Cavco Industries’ Rollercoaster: Record Highs, Big Acquisition & Housing Market Headwinds (Oct 2025 Update)

Cavco Industries’ Rollercoaster: Record Highs, Big Acquisition & Housing Market Headwinds (Oct 2025 Update)

Stock Performance Snapshot (Oct 2025) Cavco’s stock went on a rollercoaster ride in late 2025. After a steady rally through the year (+30% YTD by early October tipranks.com), CVCO surged to an all-time high around $574 per share marketbeat.com. This run-up coincided with strong earnings and optimism around affordable housing. However, on October 6, the stock sharply reversed, dropping from the mid-$570s to the high-$490s in a single session (a −12.6% plunge intraday) marketbeat.com finance.yahoo.com. This sudden sell-off wiped out about $72 per share, reflecting broader market turbulence rather than any negative Cavco news gurufocus.com. Indeed, analysts noted the downturn
7 October 2025
 ·  ·  ·  ·  · 
USA Rare Earth (USAR) Stock Skyrockets on Major UK Acquisition and White House Talks

USA Rare Earth (USAR) Stock Skyrockets on Major UK Acquisition and White House Talks

Stock Surge & Financials USA Rare Earth’s stock has been on a tear. After trading around $5–6 at the start of 2025, it climbed steadily as the company hit milestones, and on Oct 3, 2025 it burst higher. In pre-market on Oct 3, shares jumped about 10% after CEO Barbara Humpton said USAR was in “close discussions” with the White House on critical minerals supply reuters.com. This echoes reports that the Trump administration (via emergency powers) is actively boosting domestic rare-earth projects, alongside stakes in lithium companies and deals with MP Materials reuters.com investing.com. By midday Oct 3, Reuters noted USAR stock
3 October 2025
 ·  ·  ·  · 
Canada Goose (GOOS) Stock Skyrockets: Luxury Parka Maker’s Bold Moves, Price Hikes & Buyout Buzz

Canada Goose (GOOS) Stock Skyrockets: Luxury Parka Maker’s Bold Moves, Price Hikes & Buyout Buzz

Company Overview Canada Goose is a Toronto‑based premium outerwear maker. Founded in 1957 by Sam Tick, it grew from wool vests and snowsuits to a global luxury apparel brand en.wikipedia.org. Under CEO Dani Reiss (family-run since 1985), CG doubled down on “Made in Canada” quality and fashion appeal investor.canadagoose.com. Today it designs “high-performance outerwear, apparel, footwear, and accessories” inspired by Arctic conditions investor.canadagoose.com. Signature products are down‑filled parkas and cold-weather jackets, but CG has expanded into rainwear, knitwear and even summer‑ready lines reuters.com investor.canadagoose.com. Collaborations (notably with French designer Haider Ackermann) and new collections have refreshed the brand’s image reuters.com.
27 September 2025
 ·  ·  ·  · 
Go toTop